Ticker Symbol: MIST
Milestone Pharmaceuticals Inc
$6.85 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001408443
Company Profile
Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Milestone Pharmaceuticals operates in Canada and the United States.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.milestonepharma.com
CEO: N/A
Tags:
- Pharmaceuticals: Major
- Health Technology
- Manufacturing
- Medicinal and Botanical Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.96
Change:
-$0.02
(
-0.67%)
Days Range: $2.83 - $2.99
Beta: 0.73
52wk. High: $5.87
52wk. Low: $2.60
Ytd. Change -25.42%
50 Day Moving Average: $2.97
200 Day Moving Average: $3.38
Shares Outstanding: 33382769
Valuation
Market Cap: 9.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A